[{"Assets_0_Q2_USD":8106373000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":115607000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":116137000.0,"StockholdersEquity_0_Q2_USD":5520738000.0,"RevenuesConverted_2_Q2_USD":2789107000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":106034000.0,"RevenuesConverted_1_Q2_USD":1470116000.0,"NetIncomeLossConverted_1_Q2_USD":387744000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":325331000.0,"EarningsPerShareDiluted_2_Q2_USD":5.51,"EarningsPerShareDiluted_1_Q2_USD":3.34,"EarningsPerShareBasic_2_Q2_USD":6.02,"EarningsPerShareBasic_1_Q2_USD":3.66,"NetIncomeLossConverted_2_Q2_USD":636675000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":105804000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS INC","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20170803"}]